Italian law enforcement authorities are currently investing the theft. However, the situation goes beyond EU and national current practices for handling quality or product defects; these are extraordinary circumstances driven by criminal activities that require special measures and strong collaboration from authorities across the EU.
Jacques Servier, the founder of France's second-largest pharmaceutical group who became ensnared...
The European Medicines Agency (EMA) has been informed that vials of the cancer medicine...
BioAlliance Pharma SA and Topotarget A/S today announced their intention to merge to create an...
The BBC reports that pharmaceutical company GlaxoSmithKline is accused of bribing doctors to prescribe medicines in Poland. A "Panorama" show to air Monday evening quotes a former sales representative for the company saying doctors there were paid to prescribe its drugs.
Moberg Pharma AB has entered into a definitive agreement with Oracain II Aps (Denmark) to acquire all assets and global rights to a novel and patent pending oral formulation of the proven substance bupivacaine, for the treatment of pain in the oral cavity.
Swedish drug company Meda has rebuffed an approach from generic drug maker Mylan which was looking to combine the two businesses. Meda AB says talks between the two companies have stopped "without further actions."
The U.S. Food and Drug Administration has approved the first tablet for gradually reducing hay fever allergy symptoms, an alternative to uncomfortable allergy-desensitizing shots.
Evotec AG has announced a research collaboration and licensing deal with Debiopharm Group Lausanne, Switzerland. The objective of this collaboration is to identify and develop novel compounds having the potential to treat multiple forms of solid tumors and leukemias with defined genetic alterations.
Evotec AG today announced that it has entered into a research alliance with Panion Ltd, a subsidiary of Convergence Pharmaceuticals Holdings Ltd. Convergence is a UK company focused on the development of novel, high value analgesics to treat chronic pain.
England's public health agency says two people have caught tuberculosis from a pet cat, the first time the bacterial disease has been documented to spread from cat to human.
Shares of Endocyte nearly doubled in value Friday after European Union regulators said the company's drug Vynfinit should be approved as a treatment for ovarian cancer.
Horizon Pharma Inc. will acquire Vidara Therapeutics for a "tax-efficient corporate structure."
Idenix Pharmaceuticals has filed patent infringement lawsuits against Gilead Sciences and/or certain of its subsidiaries in each of three countries - France, Germany and the United Kingdom.
Intrexon Corporation, a synthetic biology company, has acquired state-of-the-art laboratory operations in Budapest, Hungary from Codexis, Inc., a developer of biocatalysts for the pharmaceutical and complex chemistry industries.
Chiesi Farmaceutici SpA, an international pharmaceutical company focused in the respiratory, neonatology and special care therapeutic areas, closed 2013 with a turnover of more than 1,236 million euro, an increase of 11.8% compared to 2012 (+14% at constant exchange rates).
AstraZeneca today announced the sale of its Alderley Park site in Cheshire, UK, to Manchester Science Parks (MSP), a Greater Manchester based public-private partnership and science park operator.
Alexion Pharmaceuticals raised its 2014 guidance on Monday, saying the national health agency of France will reimburse it for past sales of its drug Soliris.
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed a review of domperidone-containing medicines and has recommended changes to their use throughout the European Union (EU).
Endo International has appointed Susan Hall, Ph.D. as executive vice president, chief scientific officer and global head of research & development and quality, effective March 10, 2014.
Dendreon Corporation today announced that it plans to make PROVENGE ® (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.
European Medicines Agency Recommends that Protelos/Osseor Remain Available But with Further RestrictionsFebruary 21, 2014 8:23 am | News | Comments
The European Medicines Agency has concluded its review of Protelos/Osseor and has recommended further restricting the use of the medicine to patients who cannot be treated with other medicines approved for osteoporosis.
Jean-Christophe Tellier, currently UCB’s Executive Vice President, Biopharma Brands and Solutions, will be appointed Chief Executive Officer-Elect and Chairman of the Executive Committee as of March 1, 2014. Jean-Christophe Tellier will also be proposed to be appointed as a member of the Board of Directors at the next Annual General Meeting of Shareholders on April 24, 2014.
There's one big reason why the United States has a dearth of execution drugs so acute that some states are considering solutions such as firing squads and gas chambers: Europe's fierce hostility to capital punishment. The phenomenon started nine years ago when the EU banned the export of products used for execution, citing its goal to be the "leading institutional actor and largest donor to the fight against the death penalty."
Leading cancer experts say Europe's antiquated drug regulatory system is stopping children from getting life-saving medicines and are calling for changes that would remove a loophole that allows companies to skip developing medicines for children already approved for adults.
Swiss food and drink giant Nestlé and French cosmetics company L'Oréal have approved a deal to transfer ownership of Swiss dermatology pharmaceuticals company Galderma.
UPS said Tuesday that it has completed its acquisition of Polar Speed, a company that helps deliver temperature-sensitive pharmaceutical supplies in the United Kingdom. Financial terms were not disclosed.
Jazz Pharmaceuticals today announced that it has commenced construction of a manufacturing and development facility to be located on a 17-acre site in Monksland, County Roscommon, approximately 75 miles east of the company's Dublin headquarters. This is the first manufacturing facility to be built by Jazz Pharmaceuticals.
AstraZeneca and Bristol-Myers Squibb today announced that Xigduo™ (dapagliflozin and metformin hydrochloride in 5mg/850mg and 5mg/1000mg tablets) has been granted Marketing Authorization by the European Commission for the treatment of type 2 diabetes in the European Union (EU).
- Page 1